ABSTRACT Background: Caffeine is a widely used and accepted pharmacologically active substance. The effect of caffeine intake during pregnancy on fetal growth and development is still unclear. Objective: We examined the associations of maternal caffeine intake, on the basis of coffee and tea consumption, with fetal growth characteristics measured in each trimester of pregnancy and the risks of adverse birth outcomes. Design: Associations were studied in 7346 pregnant women participating in a population-based prospective cohort study from early pregnancy onward in the Netherlands (2001)(2002)(2003)(2004)(2005). Caffeine intake in the first, second, and third trimesters was on the basis of coffee and tea consumption and was assessed by questionnaires. Fetal growth characteristics were repeatedly measured by ultrasound. Information about birth outcomes was obtained from hospital records. Results: We observed no consistent associations of caffeine intake with fetal head circumference or estimated fetal weight in any trimester. Higher caffeine intake was associated with smaller firsttrimester crown-rump length, second-and third-trimester femur length, and birth length (P for trend ,0.05). Offspring of mothers who consumed 6 caffeine units/d tended to have increased risks of small-for-gestational-age infants at birth. Conclusions: Our results suggest that caffeine intake of 6 units/d during pregnancy is associated with impaired fetal length growth. Caffeine exposure might preferentially adversely affect fetal skeletal growth. Further studies are needed to assess these associations in non-European populations and to assess the postnatal consequences.
INTRODUCTION
Caffeine is a widely used and accepted pharmacologically active substance. The prevalence of the exposure is .80% in most Western countries (1) . The main exposure to caffeine is through coffee and tea consumption (2) . Maternal caffeine intake during pregnancy directly influences fetal caffeine exposure levels because caffeine freely passes through the placental barrier from the mother to the fetus (3, 4) , and the principal caffeine metabolism enzyme, cytochrome CYP1A2, is absent in the placenta and fetus (5) . Fetal exposure to caffeine increases circulating catecholamine concentrations, which might subsequently lead to fetoplacental vasoconstriction and hypoxia and eventually affect fetal growth and development (6) .
The effect of caffeine intake during pregnancy on fetal growth and development is still unclear. Previous studies have suggested that caffeine intake during pregnancy is associated with increased risks of miscarriage and fetal death (7, 8) . Similarly, some studies have suggested associations of higher maternal caffeine intakes during pregnancy with lower birth weight (9) (10) (11) (12) (13) (14) (15) (16) . However, results seem to be inconsistent (10, (17) (18) (19) (20) (21) (22) , which might be due to differences in study designs, number of included subjects, methods for obtaining accurate caffeine intake, and adjustment for potential confounders. Also, studies have focused on the associations of caffeine intake on only birth weight, because measure of fetal growth and development are not able to identify specific fetal exposures and growth patterns. Studies of various fetal growth characteristics measured in different trimesters might give clues for specific critical periods and body proportions. The same birth weight might be the result of various fetal exposures and growth patterns.
Therefore, we examined in a population-based prospective cohort study among 7346 pregnant women the associations of maternal caffeine intake, based on coffee and tea consumption, with fetal growth characteristics measured in each trimester of pregnancy and the risks of adverse birth outcomes.
SUBJECTS AND METHODS

Design
This study was embedded in the Generation R Study, a population-based prospective cohort study from fetal life until young adulthood (23, 24) . The cohort includes 9778 mothers and their children of different ethnicities living in Rotterdam, the Netherlands, and has been described in detail previously (23, 24) . All mothers were enrolled between 2001 and 2005, and all children were born between April 2002 and January 2006. Of all eligible children in the study area, 61% participated at birth in the study (24) . The Medical Ethical Committee of the Erasmus Medical Center, Rotterdam, approved the study (MEC 198.782/2001/31) . Written informed consent was obtained from all participants. Enrollment was aimed at early pregnancy (gestational age ,18 wk) at the routine fetal ultrasound examination in pregnancy, but was allowed until birth of the child. Assessments in pregnancy, including physical examinations, fetal ultrasound examinations, and questionnaires, were planned in early pregnancy (gestational age ,18.0 wk), midpregnancy (gestational age 18.0-24.9 wk), and late pregnancy (gestational age 25.0 wk). These were considered the first-, second-, and third-trimester measurements, respectively. The individual timing of these assessments depended on the gestational age at enrollment (23, 24) .
Caffeine intake
Information about maternal caffeine intake was obtained by postal questionnaires in the first, second, and third trimesters of pregnancy. Response rates for these questionnaires were 91%, 80%, and 77%, respectively. Mothers who reported any coffee or tea drinking were asked to categorize their average number of cups of coffee or tea per day and what type of coffee or tea they consumed (caffeinated, caffeinated and decaffeinated, or decaffeinated). According to standard values for caffeine content, a regular coffee serving (125 mL) in the Netherlands contains '90 mg caffeine, decaffeinated coffee contains '3 mg, and tea contains '45 mg (25) . To calculate the total caffeine intake in each trimester, we weighted the type of coffee or tea (caffeinated coffee = 1, caffeinated and decaffeinated coffee = 0.5, decaffeinated coffee = 0, caffeinated tea = 0.5, caffeinated and decaffeinated tea = 0.25, decaffeinated tea = 0; herbal tea = 0, and green tea = 0.5). Thus, in our analyses, each unit of caffeine intake reflects caffeine exposure based on 1 cup (90 mg caffeine) of caffeinated coffee. Total caffeine intake was subsequently categorized (,2 , 2-3.9, 4-5.9, and 6 units/d). We used thirdtrimester caffeine intake as exposure for both third trimester (25 wk) and birth growth characteristics ( Figure 1) . Total caffeine intakes in the first, second, and third trimesters were correlated (Spearman's correlation coefficients ranged from 0.61 to 0.72; P , 0.01). We used the mean caffeine intake during pregnancy to assess the associations with longitudinally measured fetal growth and the risks of adverse birth outcomes.
Fetal growth characteristics
Fetal ultrasound examinations were carried out in 1 of the 2 dedicated research centers in each trimester of pregnancy. These fetal ultrasound examinations were used for both establishing gestational age and assessing fetal growth characteristics (24) . In the first trimester, we used crown-rump length to assess fetal growth only in mothers with a known and reliable first day of the last menstrual period and a regular menstrual cycle of 28 (range: 24-32) days and who had crown-rump length measured between a gestational age of 10 and 15 wk. The first day of the last menstrual period was obtained from the referring letter from the community midwife or hospital. This date was confirmed with the subjects at the ultrasound visit, and additional information on the regularity and duration of cycle was obtained. Because using the last menstrual period has several limitations, such as the large number of mothers who do not know the exact date of their last menstrual period or have irregular menstrual cycles (26), gestational age was established by fetal ultrasound examination for the second-and third-trimester growth measurements. In the second and third trimesters of pregnancy, we measured head circumference, abdominal circumference, and femur length to the nearest millimeter using standardized ultrasound procedures (27) . Estimated fetal weight was subsequently calculated by using the Hadlock formula (28). 
Birth outcomes
Information about offspring sex, gestational age, weight, length, and head circumference at birth was obtained from medical records and hospital registries. Because head circumference and length at birth were not routinely measured at birth, missing birth measures were completed with data from the first month visit at the routine child health center. Of all FIGURE 1. Design of the studied cross-sectional associations between caffeine intake during pregnancy and different fetal growth indicators in the Generation R Study, Rotterdam, the Netherlands (n = 7346). CRL, crown-rump length; HC, head circumference; FL, femur length; EFW, estimated fetal weight; BL, birth length; BW, birth weight. measurements, 31% and 20% were based on the first month visit for head circumference and birth length, respectively. No differences in mean maternal caffeine intake between children with measurements at birth and those without measurements at birth were observed (t tests: P = 0.73 for head circumference and P = 0.92 for birth length). The regression models with neonatal head circumference and length as outcome were adjusted for postconceptional age (gestational age for measurements at birth or gestational age + postnatal age for measurement from the child health centers) and for the method of measurement (birth or child health center). Low birth weight was defined as birth weight ,2500 g. Small-for-gestational-age at birth was defined as a gestational age-adjusted birth weight below the 5th percentile in the study cohort (, 21.81 SD score for boys and , 21.73 SD score for girls), and preterm birth was defined as a gestational age ,37 wk at delivery.
Covariates
Information about educational level, ethnicity, parity, and folic acid supplement use was obtained by a questionnaire at enrollment in the study. Maternal smoking and alcohol habits were assessed by questionnaires in each trimester. First-trimester nutritional information (total energy intake, total carbohydrate intake, total fat intake, and total protein intake) was obtained with a food-frequency questionnaire at enrollment. Mothers who were enrolled after the first trimester of pregnancy did not receive this food-frequency questionnaire. Maternal anthropometric measurements, including height (cm) and weight (kg), were measured without shoes and heavy clothing during visits at the research center; subsequently, body mass index (kg/m 2 ) was calculated for each trimester. Maternal weight measured at enrollment in the study (median gestational age: 14.4 wk; 95% range: 10.3-26.2) was strongly correlated with prepregnancy weight (r = 0.95, P , 0.01). We used maternal weight and body mass index measured at enrollment in the analyses, because the numbers of missing values were smaller and data quality higher. These analyses were adjusted for gestational age at enrollment. Also, no differences in results were observed when we used maternal weight and body mass index based on the questionnaire data. Maternal age was registered at enrollment.
Population for analysis
A total of 8880 mothers were enrolled during pregnancy (24) . Those without any information about coffee or tea consumption during pregnancy were excluded from the analyses (14.5%, n = 1284). Those pregnancies leading to twin births (n = 80), induced abortion (n = 23), fetal death (n = 68), or loss to followup (n = 28) were excluded. Also, children with missing birth weight (n = 48) and gestational age at birth of ,25 wk (n = 3) were excluded. The associations of caffeine intake during pregnancy with fetal growth characteristics and risks of adverse birth outcomes were analyzed in the remaining 7346 mothers (Figure 2 ). Of these mothers, 5.4% were second (n = 394) or third (n = 3) pregnancies in the study. Because there were no differences in results after exclusion of these subjects, they were included in the analyses presented.
Statistical analysis
First, cross-sectional dose-response analyses in the first, second, and third trimesters and at birth were performed by using multiple linear regression models with caffeine as an independent variable and each growth characteristics as a dependent variable (Figure 1 ). We used categories of units of caffeine intake and additional tests for trends using total caffeine intake per day as continuous variable in the models. Second, we assessed the associations between maternal caffeine intake and longitudinally measured SD scores of head circumference, length (first-trimester crown-rump length, second-and third-trimester femur length, and birth length), and weight (second and third trimester estimated fetal weight, and birth weight) using unbalanced repeatedmeasurement analysis, which enables optimal use of available data, taking into account correlations within subjects and assessing both time dependent and independent associations. To calculate SD scores for each growth characteristic, we used the following formula: SD score ¼ ðobserved value 2 median value of the reference populationÞ= SD value of the reference population ð2Þ
Models were constructed for gestational age-adjusted SD scores. In total, we had 23,695 measurements for SD scores of head circumference, 20,657 measurements for SD scores of length, and 21,216 for SD scores of weight. Third, we used multiple logistic regression models to assess the associations of caffeine intake with the risks of low birth weight, small-for-gestational-age, and preterm birth. To increase the number of subjects, we combined the categories of caffeine intake into 4, instead of 5, categories (,2, 2-3.9, 4-5.9, and 6 units/d). The regression models were adjusted for lifestyle-related and socioeconomic status-related confounders used in previous studies on maternal caffeine intake (maternal height, body mass index, educational level, smoking habits, alcohol consumption, folic acid supplement use, total energy intake, total carbohydrate intake, total fat intake, and total protein intake) and known determinants of fetal growth (maternal age, maternal ethnicity, gestational diabetes, pregnancy-induced hypertension, preeclampsia, parity, and fetal sex) (29) . The percentages of missing values within the population for analysis were ,3%, except for folic acid supplement use data (14%) and nutritional data (24%). These higher percentages were due to the large number of mothers who were not enrolled in the first trimester and therefore did not receive the food-frequency questionnaire. We imputed missing data of the covariates with the mean value for continuous variables and a separate category for missing data for categorical variables. No differences in results were observed between analyses with imputed missing data or complete cases only. Also, no differences in results were observed with or without nutritional data. Therefore, only results including imputed missing data are presented.
All levels of association are presented with their 95% CIs. Cross-sectional analyses were performed by using the Statistical Package of Social Sciences version 15.0 for Windows (SPSS Inc, Chicago, IL). The unbalanced repeated-measurements analysis, including the Prox Mixed module, was performed with the Statistical Analysis System (version 9.1; SAS Institute Inc, Cary NC).
RESULTS
Subject characteristics
The mean age of the mothers in the whole cohort was 29.7 y (range: 15.3-46.3 y). Of all mothers, 46.1% (3388) were enrolled at a gestational age of ,14 wk, and 41.2% were higher educated. More than half of the mothers were of Dutch or other European ethnicity. The other largest ethnic groups were Surinamese, Turkish, and Moroccan ( Table 1) . Compared with mothers with no or ,2 caffeine units/d day, mothers consuming more caffeine tended to be older and taller and to have more previous births and be more frequently Dutch or European (see Supplementary  Table S1 under "Supplemental data" in the online issue). They were less frequently smokers and more frequently alcohol consumers. Their total dietary energy intake was higher. The mean (6 SD) birth weight of the children was 3418 6 559 g. Gestational age at birth ranged from 25.3 to 43.6 wk with a median of 40.1 wk. Of all singleton live births, 4.5% had a birth weight ,2500 g, 4.6% were small-for-gestational-age, and 4.8% were born before a gestational age of 37 wk ( Table 2) . The distribution of total caffeine intake differed between the trimesters (chi-square test, P , 0.01), as shown in Table 3 . Most mothers consumed ,2 units caffeine/d.
Total caffeine intake and fetal growth characteristics
Maternal caffeine intake was not consistently associated with fetal head circumference in the second and third trimester of pregnancy and at birth (see Supplementary Tables S2, S3, and S4 under "Supplemental data" in the online issue). Also, no consistent associations were observed between maternal caffeine intake and estimated fetal weight in the second and third trimesters. We observed tendencies toward a lower weight at birth for intake of 6 caffeine units/d (difference: 2100.27 g; 95% CI: 2197.05, 23.49) compared with mothers who did not consume any caffeine during pregnancy. However, the overall tests for trend assessing the associations between the number of caffeine units and (estimated fetal) weight were not significant. Caffeine intake tended to be inversely associated with all length measures (P for trend ,0.05 for all). Mothers who consumed 6 caffeine units/d had a smaller first-trimester fetal crown- Analyses that focused on the associations of caffeine consumption with head circumference at birth and length at birth, without imputing data from the first postnatal measurements at the child health centers, showed similar results (data not shown).
The results presented in Figure 3 (A-C) show the associations between the number of caffeine units and longitudinally measured fetal growth (head circumference, weight, and length). These results were based on repeated regression models. To compare effect estimates, the results are presented as difference in gestational age-adjusted SD scores. No consistent associations were found between the mean number of caffeine units per day and fetal head circumference growth. Compared with mothers who did not consume any caffeine-containing beverages during pregnancy, those who consumed 6 units caffeine/d showed impaired fetal weight and length growth (see Supplementary Table S5 under "Supplemental data" in the online issue).
Total caffeine intake and risks of adverse birth outcomes
Caffeine intake of 6 units/d was associated with an increased risk of low birth weight (adjusted odds ratio: 2.58; 95% CI: 1.26, 5.30). However, this effect estimate was based on small numbers (n = 9), and the overall tests for trend assessing the associations between the number of caffeine units and the risk of low birth weight were not significant. Caffeine intake was positively associated with the risks of delivering a small-forgestational-age child (P , 0.01). Compared with mothers who consumed ,2 units caffeine/d, the adjusted odds ratios were 1.38 (95% CI: 1.08, 1.76), 1.50 (95% CI: 0.96, 2.36), and 1.87 (95% CI: 0.84, 4.15) for mothers consuming 2-3.9, 4-5.9, and 6 units caffeine/d, respectively (P trend , 0.01). No associations were found between caffeine intake and the risk of preterm birth ( Table 4) .
DISCUSSION
Findings from this large population-based prospective cohort study suggest that caffeine intake of 6 units/d during pregnancy is associated with impaired fetal length growth. Length-or skeletal-related fetal growth characteristics seemed to be consistently affected from the first trimester onward. No associations were observed between caffeine intake and fetal head circumference. For fetal weight, no statistically significant associations were observed but there was a tendency toward lower fetal weight for higher caffeine intakes. In addition, we found a positive association between caffeine intake during pregnancy and the risks of offspring with a small-for-gestational-age at birth.
Methodologic considerations
The strength of this study was the large number of subjects in a prospectively studied cohort. To our knowledge, this is the largest study focused on caffeine intake during pregnancy on fetal growth characteristics in different periods of pregnancy. Compared with many previous studies, we were able to control for many possible confounders (14, 16) . However, because of the observational design, residual confounding due to sociodemographic and lifestyle factors might still be an issue. Another potential limitation of our study is the missing data on coffee and tea consumption. Missing information about coffee and tea consumption may have led to loss of power. The associations may be underestimated if, among mothers without caffeine data, the percentage was higher among consumers than among mothers without missing data. On the contrary, if mothers without caffeine data were more likely to be no or light caffeine consumers and were at risk of adverse birth outcomes, the associations might be overestimated. This seemed unlikely because no other differences in characteristics between mothers with and without information about coffee and tea consumption were observed. Of the mothers with information about coffee and tea consumption, we had a limited loss to follow-up. Therefore, we did not expect biased results due to loss to follow-up (30) . Information on coffee and tea consumption during pregnancy was collected by postal questionnaires. If any, misclassification would most likely have been due to underreporting and subsequently to underestimation of differences between doses of caffeine intake (31) . Coffee accounts for '70% of all caffeine intake, tea for 26%, and "other" (cocoa, chocolate, soft drinks, and caffeine-containing medications) for 4% (32) . Although consumption of caffeinated soft drinks is increasing (1, 30) , the analysis of only coffee and tea consumption in this study seemed sufficient to assess the effect of caffeine on the growth and development of the fetus. We categorized caffeine intake instead of calculating the exact milligrams of caffeine consumed per day. However, the highest category of caffeine intake in our study (6 units) should be considered equivalent to a caffeine intake of .540 mg/d. The amount of caffeine per coffee serving was estimated at 90 mg (25) . European coffee is typically stronger than coffee in the United States (1) . A standard coffee serving in the United States contains '70 mg caffeine. This suggests that a caffeine intake of ,7 servings per day is not associated with any adverse birth outcome in the United States. However, our results should be interpreted very carefully for non-European populations because of their higher intakes. Further studies, specifically in nonEuropean populations, are needed.
We assessed the effects of caffeine intake on crown-rump length only in mothers with a certain first day of last menstrual period and regular menstrual cycles. For second-and thirdtrimester growth measurements, gestational age was established by fetal ultrasound examination. This method appears superior to the use of the last menstrual period (24) . The major disadvantage of establishing gestational age by ultrasound is that the growth variation of the fetal characteristics used for pregnancy dating is assumed to be zero. Because pregnancy dating characteristics and growth characteristics are correlated throughout pregnancy, growth variation in head circumference and femur length may be reduced by dating the pregnancy on crown-rump length and biparietal diameter. This may have led to underestimation of our effect estimates. However, we expected this effect to be small in our study. The longitudinal analyses were focused on fetal growth during pregnancy within individuals. This relative change in size is unlikely to have been materially affected by our pregnancy dating method. Because gestational age and fetal growth were not established concurrently, we believe that we minimized the effect of pregnancy dating on growth variation. We measured fetal growth repeatedly in each trimester of pregnancy by ultrasound. These measurements were performed in dedicated research centers according to standardized protocols. Intraclass correlation coefficients for intra-and interobserver reproducibility of fetal growth measurements were .0.95 (26, 33) . Because body length cannot be measured by fetal ultrasound, we used SD FIGURE 3. Associations of caffeine intake during pregnancy with longitudinally measured growth characteristics in the Generation R Study, Rotterdam, the Netherlands (n = 7346): head circumference growth (A), weight growth (B), and length growth (C). Results are based on repeated linear regression models and reflect the differences in SD scores of head circumference (based on 23,068 measurements), weight (based on 19,519 measurements), and length (based on 20,419 measurements) growth in the offspring of mothers who consumed caffeine-containing beverages compared with those from mothers who did not consume caffeinecontaining beverages. The reference value is an SD score of 0. *P , 0.05. The corresponding effect estimates and their CIs are provided in Supplementary Table S5 under "Supplemental data" in the online issue.
scores of crown-rump length, femur length, and birth length as measures of fetal length to assess relative changes in fetal skeletal growth. Results from these combined repeated regression models should be interpreted carefully because these measurements might reflect different body parts, because we used crown-rump length, femur length, and body length as length measurements throughout pregnancy.
Caffeine intake and fetal growth
Caffeine crosses the placental barrier easily, where it can directly affect the fetus in several different aspects. The half-life of caffeine is greatly increased in pregnancy, because it cannot be metabolized by the fetus or the placenta (34) . In the first trimester, the half-life is '10 h, whereas it increases up to 18 h during the third trimester, because the enzymes in the human liver do not exist until the 8 month of life (35, 36) . Previous studies focused primarily on the associations between caffeine intake during pregnancy and birth weight and showed inconsistent associations (10, 17-22, 37, 38) . Moreover, most studies used low birth weight as an outcome measurement instead of actual fetal growth. Examining fetal growth characteristics instead of birth weight is a more appropriate approach to assess the effects of caffeine intake during pregnancy. This enables identification of specific critical periods during pregnancy for the exposure on various patterns of fetal growth and development. We found negative associations between caffeine intakes and weight and length growth. Previous results from the CARE Study Group (16) suggest adverse effects of caffeine consumption on fetal growth at lower intakes. This difference might be due to differences in study design and populations. Also, calculations of caffeine intake should be interpreted carefully and might be country specific. We found consistent effects on fetal growth measures, which reflect skeletal growth. These measures include first-trimester crown-rump length and second-and thirdtrimester femur length and birth length. Although these measures reflect different body proportions, they seem to be consistent. Caffeine intake might selectively affect bone and skeletal development. Further follow-up studies are needed that focus on the effects of fetal caffeine exposure on postnatal skeletal and bone measurements.
Conclusions
We showed that caffeine intake of 6 units/d during pregnancy is associated with impaired fetal weight and length growth. Length-or skeletal-related fetal growth characteristics seemed to be most consistently affected from the first trimester onward. Further structural and functional studies are needed to assess organ-specific effects. Our results suggest that pregnant women should be advised to not consume 6 caffeine units (.540 mg) per day during pregnancy. The authors' responsibilities were as follows-RB, EAPS, AO, and VWVJ: designed and implemented the study, designed the study's analytical strategy, performed the literature review, and prepared the text; and HR and AH: advised on the design of the study and directed its implementation, designed the study's analytical strategy, supervised the field activities, 
